Identification and Validation of Key Extracellular Proteins As the Potential Biomarkers in Diabetic Nephropathy

Overview

Journal Eur J Med Res

Publisher Biomed Central

Specialty General Medicine

Date 2024 Oct 26

PMID 39456069

Authors

Wei Pan

Qiankun Zhang

Xiaohua Gong

Wenjun Wu

Qi Zhou

Affiliations

Soon will be listed here.

Abstract

Objective: Accumulation of extracellular matrix (ECM) proteins in the glomerular mesangial region is a typical hallmark of diabetic nephropathy (DN). However, the molecular mechanism underlying ECM accumulation in the mesangium of DN patients remains unclear. The present study aims to establish a connection between extracellular proteins and DN with the goal of identifying potential biomarkers for this condition.

Methods: Differentially expressed genes (DEGs) between DN kidney tissue and healthy kidney tissue were analyzed using the public data GSE166239. Two gene lists encoding extracellular proteins were then utilized to identify extracellular protein-differentially expressed genes (EP-DEGs). Functional enrichment analyses, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, were performed on these EP-DEGs. A protein-protein interaction (PPI) network was established to identify key EP-DEGs. Furthermore, the diagnostic ability, immune cell infiltration, and clinical relevance of these EP-DEGs were investigated. Immunohistochemistry (IHC) staining of paraffin-embedded renal tissues was performed to validate the accuracy of the bioinformatic results.

Results: A total of 1204 DEGs were identified, from which 162 EP-DEGs were further characterized by overlapping with extracellular protein gene lists. From the PPI network analysis, five EP-DEGs (e.g., TNF, COL1A1, FN1, MMP9, and TGFB1) were identified as candidate biomarkers. TNF, COL1A1, and MMP9 had a high diagnostic accuracy for DN. Assessment of immune cell infiltration revealed that the expression of TNF was positively associated with resting dendritic cells (DCs) (r = 0.85, P < 0.001) and M1 macrophages (r = 0.62, P < 0.05), whereas negatively associated with regulatory T cells (r = - 0.62, P < 0.05). Nephroseq v5 analysis demonstrated a negative correlation between the estimated glomerular filtration rate (eGFR) and TNF expression (r = - 0.730, P = 0.025). Gene set enrichment analysis (GSEA) revealed significant enrichment of glycosaminoglycan (GAG) degradation in the high-TNF subgroup. IHC staining of renal tissues confirmed significantly elevated TNF-a expression and decreased hyaluronic acid (HA) levels in the DN group compared to controls (both P < 0.05), with a negative correlation observed between TNF-a and HA (r = - 0.691, P = 0.026).

Conclusion: Our findings suggest that TNF may play a pivotal role in the progress of DN by driving ECM accumulation, and this process might involve GAG degradation pathway activation.

Citing Articles

Inhibition of complement system-related gene ITGB2 attenuates epithelial-mesenchymal transition and inflammation in diabetic nephropathy.

Peng J, Zhao W, Zhou L, Ding K Eur J Med Res. 2025; 30(1):87.

PMID: 39920798 PMC: 11806615. DOI: 10.1186/s40001-025-02323-x.

References

Thomas H, Ford Versypt A . Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation. J Biol Eng. 2022; 16(1):19. PMC: 9347079. DOI: 10.1186/s13036-022-00299-4. View

Kanwar Y, Wada J, Sun L, Xie P, Wallner E, Chen S . Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood). 2007; 233(1):4-11. DOI: 10.3181/0705-MR-134. View

Kuppe C, Ibrahim M, Kranz J, Zhang X, Ziegler S, Perales-Paton J . Decoding myofibroblast origins in human kidney fibrosis. Nature. 2020; 589(7841):281-286. PMC: 7611626. DOI: 10.1038/s41586-020-2941-1. View

Anders H, Huber T, Isermann B, Schiffer M . CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018; 14(6):361-377. DOI: 10.1038/s41581-018-0001-y. View

Wada J, Makino H . Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol. 2015; 12(1):13-26. DOI: 10.1038/nrneph.2015.175. View

Gambaro G, Venturini A, Noonan D, Fries W, Re G, Garbisa S . Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int. 1994; 46(3):797-806. DOI: 10.1038/ki.1994.335. View

Fineberg D, Jandeleit-Dahm K, Cooper M . Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol. 2013; 9(12):713-23. DOI: 10.1038/nrendo.2013.184. View

Macagno A, Napolitani G, Lanzavecchia A, Sallusto F . Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol. 2007; 28(5):227-33. DOI: 10.1016/j.it.2007.03.008. View

Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y . mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes. 1993; 42(3):450-6. DOI: 10.2337/diab.42.3.450. View

10.

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

11.

Sharma K, McGowan T . TGF-beta in diabetic kidney disease: role of novel signaling pathways. Cytokine Growth Factor Rev. 2000; 11(1-2):115-23. DOI: 10.1016/s1359-6101(99)00035-0. View

12.

Kashihara N, Haruna Y, Kondeti V, Kanwar Y . Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010; 17(34):4256-69. PMC: 3708695. DOI: 10.2174/092986710793348581. View

13.

Kim S, Lee J, Shim K, Lee S, Min K, Bae J . Attenuation of inflammation and cartilage degradation by sulfasalazine-containing hyaluronic acid on osteoarthritis rat model. Int J Biol Macromol. 2018; 114:341-348. DOI: 10.1016/j.ijbiomac.2018.03.059. View

14.

Roshandel D, Chen Z, Canty A, Bull S, Natarajan R, Paterson A . DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes. Clin Epigenetics. 2020; 12(1):52. PMC: 7132894. DOI: 10.1186/s13148-020-00840-6. View

15.

Wahida A, Muller M, Hiergeist A, Popper B, Steiger K, Branca C . XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells. Sci Immunol. 2021; 6(65):eabf7235. DOI: 10.1126/sciimmunol.abf7235. View

16.

Gnudi L, Thomas S, Viberti G . Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism. J Am Soc Nephrol. 2007; 18(8):2226-32. DOI: 10.1681/ASN.2006121362. View

17.

Alicic R, Rooney M, Tuttle K . Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol. 2017; 12(12):2032-2045. PMC: 5718284. DOI: 10.2215/CJN.11491116. View

18.

Busch M, Franke S, Ruster C, Wolf G . Advanced glycation end-products and the kidney. Eur J Clin Invest. 2010; 40(8):742-55. DOI: 10.1111/j.1365-2362.2010.02317.x. View

19.

Nguyen D, Ping F, Mu W, Hill P, Atkins R, Chadban S . Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton). 2006; 11(3):226-31. DOI: 10.1111/j.1440-1797.2006.00576.x. View

20.

van Loo G, Bertrand M . Death by TNF: a road to inflammation. Nat Rev Immunol. 2022; 23(5):289-303. PMC: 9665039. DOI: 10.1038/s41577-022-00792-3. View